TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL ENT TREATMENT MARKET, BY DEVICES
6.1. Overview
6.2. Hearing Aid Devices
6.3. Voice Prosthesis
6.4. Nasal Splints
6.5. Hearing Implants
6.6. Endoscopes
6.7. Others
7. GLOBAL ENT TREATMENT MARKET, BY DRUG TYPE
7.1. Overview
7.2. Antibiotics
7.3. Antihistamines
7.4. Steroids
7.5. Anti-inflammatory Drugs
7.6. Others
8. GLOBAL ENT TREATMENT MARKET, BY ORGAN TYPE
8.1. Overview
8.2. Ear
8.3. Nose
8.4. Throat
9. GLOBAL ENT TREATMENT MARKET, BY END-USER
9.1. Overview
9.2. Hospitals
9.3. Clinics
9.4. Ambulatory Surgical Centers
9.5. Home Care Settings
9.6. Others
10. GLOBAL ENT TREATMENT MARKET, BY REGION
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. India
10.4.3. Japan
10.4.4. South Korea
10.4.5. Australia
10.4.6. Rest of Asia-Pacific
10.5. Rest of the World
10.5.1. Middle East
10.5.2. Africa
10.5.3. Latin America
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global ENT Treatment Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global ENT Treatment Market,
11.7. Key developments and Growth Strategies
11.7.1. New Devices Launch/Drug Type Organ Type
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2022
11.8.2. Major Players R&D Expenditure. 2022
12. COMPANY PROFILES
12.1. NOVARTIS AG
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Devicess Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Pfizer Inc.
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Devicess Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. GLAXOSMITHKLINE PHARMACEUTICALS
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Devicess Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Teva Pharmaceuticals Industries Ltd.
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Devicess Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Sonova Holding AG
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Devicess Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. STARKEY LABORATORIES INC..
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Devicess Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Siemens Healthcare
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Devicess Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Sonic Innovations Inc..
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Devicess Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. American Hearing Systems Inc.
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Devicess Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Dr. Reddy’s Laboratories Ltd..
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Devicess Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL ENT TREATMENT MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL ENT TREATMENT MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 6 GLOBAL ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 10 NORTH AMERICA ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 11 NORTH AMERICA ENT TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 12 U.S. ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 13 U.S. ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 14 U.S. ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 15 U.S. ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 16 CANADA ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 17 CANADA ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 18 CANADA ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 19 CANADA ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 20 EUROPE ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 21 EUROPE ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 22 EUROPE ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 23 EUROPE ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 24 EUROPE ENT TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 25 GERMANY ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 26 GERMANY ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 27 GERMANY ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 28 GERMANY ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 29 FRANCE ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 30 FRANCE ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 31 FRANCE ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 32 FRANCE ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 33 ITALY ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 34 ITALY ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 35 ITALY ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 36 ITALY ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 37 SPAIN ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 38 SPAIN ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 39 SPAIN ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 40 SPAIN ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 41 U.K ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 42 U.K ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 43 U.K ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 44 U.K ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 45 REST OF EUROPE ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 46 REST OF EUROPE ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 47 REST OF EUROPE ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 48 REST OF EUROPE ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 49 ASIA PACIFIC ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 50 ASIA PACIFIC ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 51 ASIA PACIFIC ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 52 ASIA PACIFIC ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 53 ASIA PACIFIC ENT TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 54 JAPAN ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 55 JAPAN ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 56 JAPAN ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 57 JAPAN ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 58 CHINA ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 59 CHINA ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 60 CHINA ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 61 CHINA ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 62 INDIA ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 63 INDIA ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 64 INDIA ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 65 INDIA ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 66 AUSTRALIA ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 67 AUSTRALIA ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 68 AUSTRALIA ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 69 AUSTRALIA ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 70 SOUTH KOREA ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 71 SOUTH KOREA ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 72 SOUTH KOREA ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 73 SOUTH KOREA ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 74 REST OF ASIA-PACIFIC ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 75 REST OF ASIA-PACIFIC ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 76 REST OF ASIA-PACIFIC ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 77 REST OF ASIA-PACIFIC ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 78 REST OF WORLD ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 79 REST OF WORLD ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 80 REST OF WORLD ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 81 REST OF WORLD ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 82 REST OF WORLD ENT TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 83 MIDDLE EAST ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 84 MIDDLE EAST ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 85 MIDDLE EAST ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 86 MIDDLE EAST ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 87 AFRICA ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 88 AFRICA ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 89 AFRICA ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 90 AFRICA ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 91 LATIN AMERICA ENT TREATMENT MARKET, BY DEVICES, 2018-2032 (USD BILLION)
TABLE 92 LATIN AMERICA ENT TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 93 LATIN AMERICA ENT TREATMENT MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 94 LATIN AMERICA ENT TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ENT TREATMENT MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ENT TREATMENT MARKET
FIGURE 4 GLOBAL ENT TREATMENT MARKET, SHARE (%), BY DEVICES, 2022
FIGURE 5 GLOBAL ENT TREATMENT MARKET, SHARE (%), BY DRUG TYPE, 2022
FIGURE 6 GLOBAL ENT TREATMENT MARKET, SHARE (%), BY ORGAN TYPE, 2022
FIGURE 7 GLOBAL ENT TREATMENT MARKET, SHARE (%), BY END-USER, 2022
FIGURE 8 GLOBAL ENT TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 NORTH AMERICA: ENT TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 EUROPE: ENT TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 ASIA-PACIFIC: ENT TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 REST OF THE WORLD: ENT TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 GLOBAL ENT TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 14 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 NOVARTIS AG: SWOT ANALYSIS
FIGURE 16 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 PFIZER INC.: SWOT ANALYSIS
FIGURE 18 GLAXOSMITHKLINE PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 GLAXOSMITHKLINE PHARMACEUTICALS: SWOT ANALYSIS
FIGURE 20 TEVA PHARMACEUTICALS INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 TEVA PHARMACEUTICALS INDUSTRIES LTD.: SWOT ANALYSIS
FIGURE 22 SONOVA HOLDING AG.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 SONOVA HOLDING AG.: SWOT ANALYSIS
FIGURE 24 STARKEY LABORATORIES INC..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 STARKEY LABORATORIES INC..: SWOT ANALYSIS
FIGURE 26 SIEMENS HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 SIEMENS HEALTHCARE: SWOT ANALYSIS
FIGURE 28 SONIC INNOVATIONS INC..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 SONIC INNOVATIONS INC..: SWOT ANALYSIS
FIGURE 30 AMERICAN HEARING SYSTEMS INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 AMERICAN HEARING SYSTEMS INC.: SWOT ANALYSIS
FIGURE 32 DR. REDDY’S LABORATORIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 DR. REDDY’S LABORATORIES LTD.: SWOT ANALYSIS
